查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807695

细胞·基因治疗临床实验的全球市场:市场规模·占有率·趋势，产业分析 (各期·各适应症·各地区)，2025～2034年的市场预测

Cell and Gene Therapy Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，细胞和基因治疗临床试验市场规模将达到 448.3 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

细胞和基因治疗临床试验市场是指使用基因改造细胞或直接基因编辑技术的临床试验疗法，透过结构化试验来评估其安全性、有效性和人体治疗效果的生态系统。由于对各种慢性和罕见疾病的治癒性治疗需求不断增长，该市场正在迅速扩张。精准医疗和标靶治疗的推动正在增加对早期研究的投入，从而促使活跃临床试验数量激增。投资者和市场参与者正专注于新型平台，例如基于 CRISPR 的基因编辑、自体细胞疗法和体内递送系统，以改善治疗效果。透过加速途径和孤儿药资格认定增加监管支持，正在缩短临床试验时间并降低开发风险。产业趋势正转向分散化和自适应性试验设计，以改善招募、增强数据收集并扩大覆盖不同患者群体的管道。

生产可扩展性和冷链物流的创新也提高了复杂产品临床试验的可行性。随着生物技术公司、学术机构和合约研究组织之间日益增多的合作有助于简化试验设计和执行，机会正在扩大。高阶数据分析和远端监控工具的整合正在透过提供即时洞察和增强方案合规性，进一步改变这些试验的进行方式。数位生物标记物和人工智慧也被用于识别患者亚组并优化入组策略。竞争的焦点仍然是加速开发，同时确保临床试验的完整性、病患安全并符合不断变化的监管预期。

细胞与基因治疗临床试验市场：分析概述

按阶段划分，III期临床试验将占市场主导地位，到2024年将占总收入的55%。这是由于越来越多的先进细胞和基因治疗候选药物进入关键的临床试验阶段。

按适应症划分，肿瘤治疗将在2024年占最大的收入占有率，这得益于针对各种癌症类型的活跃细胞和基因治疗试验。

由于北美拥有强大的研究基础设施、较高的临床试验密度以及经验丰富的专家资源，北美细胞和基因治疗临床试验市场将在2024年占总收入的约50%。

预计亚太市场将在2025年至2034年期间实现最高的复合年增长率，这得益于临床研究基础设施的快速扩张以及政府对生物技术创新的支持力度的加大。

主要的全球公司包括 Charles River Laboratories、ICON Plc、IQVIA、LabCorp、Medpace、Novotech、PAREXEL International Corp.、Syneos Health、Thermo Fisher Scientific, Inc. 和 Veristat, LLC。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球细胞·基因治疗临床实验市场洞察

  • 市场概述
  • 细胞·基因治疗临床实验的市场动态
    • 促进因素和机会
      • 罕见疾病和遗传疾病高发生率
      • 先进疗法研发投入不断增加
    • 阻碍因素与课题
      • 高初始投资
  • 大环境分析
  • 细胞·基因治疗临床实验市场趋势
  • 价值链分析

第5章 全球细胞·基因治疗临床实验市场:各期

  • 主要调查结果
  • 简介
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第6章 全球细胞·基因治疗临床实验市场:各适应症

  • 主要调查结果
  • 简介
  • 肿瘤
  • 心臟病
  • 中枢神经系统疾病
  • 肌肉骨骼疾病
  • 感染疾病
  • 皮肤疾病
  • 内分泌，代谢，遗传疾病
  • 免疫疾病·发炎
  • 眼科疾病
  • 血液疾病
  • 消化器官内科疾病
  • 其他

第7章 全球细胞·基因治疗临床实验市场:各地区

  • 主要的分析结果
  • 简介
    • 细胞·基因治疗临床实验市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:各期(2020～2034年)
    • 北美:各适应症(2020～2034年)
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲:各阶段(2020～2034年)
    • 欧洲:各适应症(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各期(2020～2034年)
    • 亚太地区:各适应症(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各期(2020～2034年)
    • 中东·非洲:各适应症(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各期(2020～2034年)
    • 南美:各征兆(2020～2034年)
    • 巴西
    • 阿根廷
    • 其他南美国家

第8章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第9章 企业简介

  • Charles River Laboratories
  • ICON Plc
  • IQVIA
  • LabCorp
  • Medpace
  • Novotech
  • PAREXEL International Corp.
  • Syneos Health
  • Thermo Fisher Scientific, Inc.
  • Veristat, LLC
Product Code: PM6185

The cell and gene therapy clinical trials market size is expected to reach USD 44.83 billion by 2034, according to a new study by Polaris Market Research. The report "Cell and Gene Therapy Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cell and gene therapy clinical trials market refers to the ecosystem where investigational therapies using genetically modified cells or direct gene-editing techniques undergo structured testing to assess safety, efficacy, and therapeutic impact in humans. This market is expanding rapidly due to the rising demand for curative treatments across a range of chronic and rare conditions. The push for precision medicine and targeted intervention is increasing investments in early-stage research, leading to a sharp rise in the number of active trials. Investors and market players are focusing on novel platforms such as CRISPR-based gene editing, autologous cell therapies, and in vivo delivery systems to improve therapeutic outcomes. Increased regulatory support through expedited pathways and orphan drug designations is accelerating trial timelines and reducing developmental risks. Industry trends are moving toward decentralized and adaptive trial designs to improve recruitment, enhance data capture, and increase access for diverse patient populations.

Innovation in manufacturing scalability and cold chain logistics is also improving trial feasibility for complex products. Opportunities are expanding due to rising partnerships between biotech firms, academic institutions, and contract research organizations, which help streamline trial design and execution. Integration of advanced data analytics and remote monitoring tools is further transforming the way these trials are conducted, offering real-time insights and enhancing protocol compliance. Market players are also leveraging digital biomarkers and artificial intelligence to better identify patient subgroups and optimize enrollment strategies. The competitive focus remains on accelerating development while ensuring trial integrity, patient safety, and alignment with evolving regulatory expectations.

Cell and Gene Therapy Clinical Trials Market Report Highlights

By phase, the phase III segment dominated the market in 2024 with ~55% of the revenue share due to the growing number of advanced-stage cell and gene therapy candidates entering pivotal testing stages.

Based on indication, the oncology segment held the largest revenue share in 2024 due to the high number of active cell and gene therapy trials targeting various cancer types

The North America cell and gene therapy clinical trials market accounted for ~50% of the revenue share in 2024 due to the region's strong research infrastructure, high clinical trial density, and access to skilled professionals.

The market in Asia Pacific is expected to register the highest CAGR from 2025 to 2034 due to the rapid expansion of clinical research infrastructure and increased government support for biotech innovation.

A few global key players include Charles River Laboratories; ICON Plc; IQVIA; LabCorp; Medpace; Novotech; PAREXEL International Corp.; Syneos Health; Thermo Fisher Scientific, Inc.; Veristat, LLC.

Polaris Market Research has segmented the cell and gene therapy clinical trials market report on the basis of phase, indication, and region:

By Phase Outlook (Revenue, USD Billion, 2020-2034)

Phase I

Phase II

Phase III

Phase IV

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Cardiology

CNS

Musculoskeletal

Infectious Diseases

Dermatology

Endocrine, Metabolic, Genetic

Immunology & Inflammation

Ophthalmology

Hematology

Gastroenterology

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell and Gene Therapy Clinical Trials Market Insights

  • 4.1. Cell and Gene Therapy Clinical Trials Market - Market Snapshot
  • 4.2. Cell and Gene Therapy Clinical Trials Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High Prevalence of Rare and Genetic Disorders
      • 4.2.1.2. Rising R&D Investment in Advanced Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell and Gene Therapy Clinical Trials Market Indication Trends
  • 4.6. Value Chain Analysis

5. Global Cell and Gene Therapy Clinical Trials Market, by Phase

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • 5.3. Phase I
    • 5.3.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase I, by Region, 2020-2034 (USD Billion)
  • 5.4. Phase II
    • 5.4.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase II, by Region, 2020-2034 (USD Billion)
  • 5.5. Phase III
    • 5.5.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase III, by Region, 2020-2034 (USD Billion)
  • 5.6. Phase IV
    • 5.6.1. Global Cell and Gene Therapy Clinical Trials Market, by Phase IV, by Region, 2020-2034 (USD Billion)

6. Global Cell and Gene Therapy Clinical Trials Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 6.3. Oncology
    • 6.3.1. Global Cell and Gene Therapy Clinical Trials Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 6.4. Cardiology
    • 6.4.1. Global Cell and Gene Therapy Clinical Trials Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 6.5. CNS
    • 6.5.1. Global Cell and Gene Therapy Clinical Trials Market, by CNS, by Region, 2020-2034 (USD Billion)
  • 6.6. Musculoskeletal
    • 6.6.1. Global Cell and Gene Therapy Clinical Trials Market, by Musculoskeletal, by Region, 2020-2034 (USD Billion)
  • 6.7. Infectious diseases
    • 6.7.1. Global Cell and Gene Therapy Clinical Trials Market, by Infectious diseases, by Region, 2020-2034 (USD Billion)
  • 6.8. Dermatology
    • 6.8.1. Global Cell and Gene Therapy Clinical Trials Market, by Dermatology, by Region, 2020-2034 (USD Billion)
  • 6.9. Endocrine, metabolic, genetic
    • 6.9.1. Global Cell and Gene Therapy Clinical Trials Market, by Endocrine, metabolic, genetic, by Region, 2020-2034 (USD Billion)
  • 6.10. Immunology & inflammation
    • 6.10.1. Global Cell and Gene Therapy Clinical Trials Market, by Immunology & inflammation, by Region, 2020-2034 (USD Billion)
  • 6.11. Ophthalmology
    • 6.11.1. Global Cell and Gene Therapy Clinical Trials Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
  • 6.12. Hematology
    • 6.12.1. Global Cell and Gene Therapy Clinical Trials Market, by Hematology, by Region, 2020-2034 (USD Billion)
  • 6.13. Gastroenterology
    • 6.13.1. Global Cell and Gene Therapy Clinical Trials Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
  • 6.14. Others
    • 6.14.1. Global Cell and Gene Therapy Clinical Trials Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cell and Gene Therapy Clinical Trials Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Cell and Gene Therapy Clinical Trials Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Cell and Gene Therapy Clinical Trials Market - North America
    • 7.3.1. North America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.3.2. North America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.3. Cell and Gene Therapy Clinical Trials Market - U.S.
      • 7.3.3.1. U.S.: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.4. Cell and Gene Therapy Clinical Trials Market - Canada
      • 7.3.4.1. Canada: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.5. Cell and Gene Therapy Clinical Trials Market - Mexico
      • 7.3.5.1. Mexico: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.3.5.2. Mexico: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 7.4. Cell and Gene Therapy Clinical Trials Market - Europe
    • 7.4.1. Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.3. Cell and Gene Therapy Clinical Trials Market - UK
      • 7.4.3.1. UK: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.4. Cell and Gene Therapy Clinical Trials Market - France
      • 7.4.4.1. France: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.5. Cell and Gene Therapy Clinical Trials Market - Germany
      • 7.4.5.1. Germany: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.6. Cell and Gene Therapy Clinical Trials Market - Italy
      • 7.4.6.1. Italy: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.7. Cell and Gene Therapy Clinical Trials Market - Spain
      • 7.4.7.1. Spain: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.8. Cell and Gene Therapy Clinical Trials Market - Netherlands
      • 7.4.8.1. Netherlands: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.9. Cell and Gene Therapy Clinical Trials Market - Russia
      • 7.4.9.1. Russia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.10. Cell and Gene Therapy Clinical Trials Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 7.5. Cell and Gene Therapy Clinical Trials Market - Asia Pacific
    • 7.5.1. Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.3. Cell and Gene Therapy Clinical Trials Market - China
      • 7.5.3.1. China: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.4. Cell and Gene Therapy Clinical Trials Market - India
      • 7.5.4.1. India: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.5. Cell and Gene Therapy Clinical Trials Market - Malaysia
      • 7.5.5.1. Malaysia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.6. Cell and Gene Therapy Clinical Trials Market - Japan
      • 7.5.6.1. Japan: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.7. Cell and Gene Therapy Clinical Trials Market - Indonesia
      • 7.5.7.1. Indonesia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.8. Cell and Gene Therapy Clinical Trials Market - South Korea
      • 7.5.8.1. South Korea: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.9. Cell and Gene Therapy Clinical Trials Market - Australia
      • 7.5.9.1. Australia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.10. Cell and Gene Therapy Clinical Trials Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 7.6. Cell and Gene Therapy Clinical Trials Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.3. Cell and Gene Therapy Clinical Trials Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.4. Cell and Gene Therapy Clinical Trials Market - UAE
      • 7.6.4.1. UAE: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.5. Cell and Gene Therapy Clinical Trials Market - Israel
      • 7.6.5.1. Israel: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.6. Cell and Gene Therapy Clinical Trials Market - South Africa
      • 7.6.6.1. South Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.7. Cell and Gene Therapy Clinical Trials Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • 7.7. Cell and Gene Therapy Clinical Trials Market - Latin America
    • 7.7.1. Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.3. Cell and Gene Therapy Clinical Trials Market - Brazil
      • 7.7.3.1. Brazil: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.7.3.2. Brazil: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.4. Cell and Gene Therapy Clinical Trials Market - Argentina
      • 7.7.4.1. Argentina: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.7.4.2. Argentina: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.5. Cell and Gene Therapy Clinical Trials Market - Rest of Latin America
      • 7.7.5.1. Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
      • 7.7.5.2. Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Charles River Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. ICON Plc
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. IQVIA
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. LabCorp
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Medpace
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Novotech
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. PAREXEL International Corp.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Syneos Health
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Thermo Fisher Scientific, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Veristat, LLC
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

  • Table 1 Global Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 2 Global Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 3 North America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 4 North America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 5 U.S.: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 6 U.S.: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 7 Canada: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 8 Canada: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 9 Mexico: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 10 Mexico: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 11 Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 12 Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 13 UK: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 14 UK: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 15 France: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 16 France: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 17 Germany: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 18 Germany: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 19 Italy: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 20 Italy: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 21 Spain: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 22 Spain: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 23 Netherlands: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 24 Netherlands: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 25 Russia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 26 Russia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 27 Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 28 Rest of Europe: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 29 Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 30 Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 31 China: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 32 China: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 33 India: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 34 India: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 35 Malaysia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 36 Malaysia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 37 Japan: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 38 Japan: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 39 Indonesia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 40 Indonesia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 41 South Korea: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 42 South Korea: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 43 Australia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 44 Australia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 45 Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 46 Rest of Asia Pacific: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 47 Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 48 Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 49 Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 50 Saudi Arabia: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 51 UAE: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 52 UAE: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 53 Israel: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 54 Israel: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 55 South Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 56 South Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 57 Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 58 Rest of Middle East & Africa: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 59 Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 60 Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 61 Brazil: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 62 Brazil: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 63 Argentina: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 64 Argentina: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Cell and Gene Therapy Clinical Trials Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Phase
  • Figure 7. Global Cell and Gene Therapy Clinical Trials Market, by Phase, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Indication
  • Figure 9. Global Cell and Gene Therapy Clinical Trials Market, by Indication, 2024 & 2034 (USD Billion)